ARTICLE | Clinical News
Baraclude entecavir regulatory update
May 1, 2006 7:00 AM UTC
CHMP issued a positive opinion for Baraclude for the treatment of hepatitis B infection. A decision for the cyclopentile guanosine nucleoside analog is expected in early July. ...